论文部分内容阅读
目的探讨自膨胀、可完全收回的支架(Solitaire AB;ev3 Inc,California)在急性缺血性脑卒中血管再通治疗中的有效性及安全性。方法回顾性分析16例以颈内动脉和(或)大脑中动脉阻塞出现临床症状的缺血性脑卒中患者的临床资料,探讨在发病8 h内单独使用Solitaire AB支架行脑动脉血栓取出术的治疗方法与疗效,包括美国国立卫生院卒中量表NIHSS评分、治疗时间。结果所有患者在股动脉穿刺后90 min内完成血栓取出术,平均时间60 min,无一例患者在支架释放、去除血栓后需要其他辅助治疗,无与操作相关并发症出现。60%的患者在3个月后功能完全恢复。结论 Solitaire AB支架能迅速、安全、有效地达到血管再通、移除血栓,而不必终生支架置入的目的,可以作为一种有效的治疗方法,能降低病死率,减少并发症,改善患者预后。
Objective To investigate the efficacy and safety of self-expanding, fully retractable stent (Solitaire AB; ev3 Inc, California) in revascularization of acute ischemic stroke. Methods The clinical data of 16 patients with ischemic stroke who had clinical symptoms of occlusion of the internal carotid artery and / or middle cerebral artery were retrospectively analyzed. The patients underwent Solitaire AB stent alone within 8 h after onset of cerebral arterial thrombosis Treatment and efficacy, including the National Institutes of Health Stroke NIHSS score, treatment time. Results All patients underwent thrombectomy within 90 min after the puncture of the femoral artery, with a mean time of 60 min. None of the patients were released on the stent. Other adjuvant therapy was required after the thrombus was removed. No complication related to the operation was found. Sixty percent of patients fully regained their function after 3 months. Conclusion The Solitaire AB stent can rapidly, safely and effectively achieve the purpose of revascularization and thrombus removal without the need of lifetime stent implantation, which can be used as an effective treatment to reduce the mortality, reduce the complications and improve the prognosis .